findmyKOL
Clinical trialNCT07344558RecruitingPhase 1Interventional

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

SponsorMannkind CorporationEnrollment24Idiopathic Pulmonary Fibrosis (IPF)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Valdi

    Fresno, California, United States

    Vijay Balasubramanian, MD
    Recruiting
  • Palmtree Clinical Research

    Palm Springs, California, United States

    Ayad Gharghoury, MD
    Recruiting
  • Innova Pharma Research

    Doral, Florida, United States

    Giralt Yanez, MD
    Recruiting
  • New Life Medical Research

    Hialeah, Florida, United States

    Armand Bermudez, MD
    Recruiting
  • New Access Research and Medical Services

    Miami, Florida, United States

    Andres Redondo, MD
    Recruiting
  • Southeastern Research Center

    Winston-Salem, North Carolina, United States

    Hassan Yousef, MD
    Recruiting
  • Low Country Research

    Charleston, South Carolina, United States

    Thomas Kaelin, DO, FCCP
    Recruiting
  • Metroplex Pulmomary & Sleep Center

    McKinney, Texas, United States

    Shahrukh Kureishy, MD
    Recruiting
  • Pulmonary Medicine Consultants

    McKinney, Texas, United States

    Rashid Rahman, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Dec 2025
Primary completion
15 Jun 2026
Completion
15 Jun 2026
Last update posted
5 May 2026
Registered enrollment
24
Registry id
NCT07344558

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.